Ertugliflozin bulk supplier for pharma manufacturers

Ertugliflozin 5 mg, 15 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg, 15 mg

Reference Brands: Steglatro (USA/EU)

Category: Diabetes

Ertugliflozin is a SGLT2 (sodium-glucose co-transporter 2) inhibitor used to manage type 2 diabetes mellitus. It works by blocking glucose reabsorption in the kidneys, promoting urinary glucose excretion, and helping lower blood sugar levels.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Ertugliflozin — third party manufacturing & bulk supply

Ertugliflozin 5 mg, 15 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ertugliflozin is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ertugliflozin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ertugliflozin →

Back to Listing

Frequently Asked Questions

Ertugliflozin is listed as Tablets in 5 mg, 15 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ertugliflozin is referenced against Steglatro (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.